Michael Connolly - Net Worth and Insider Trading

Michael Connolly Net Worth

The estimated net worth of Michael Connolly is at least $0 dollars as of 2024-09-23. Michael Connolly is the Director of Mydecine Innovations Group Inc and owns about 0 shares of Mydecine Innovations Group Inc (XCNQ:MYCO) stock worth over $0. Details can be seen in Michael Connolly's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Connolly has not made any transactions after 2021-02-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Michael Connolly

To

Michael Connolly Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Connolly owns 1 companies in total, including Mydecine Innovations Group Inc (XCNQ:MYCO) .

Click here to see the complete history of Michael Connolly’s form 4 insider trades.

Insider Ownership Summary of Michael Connolly

Ticker Comapny Transaction Date Type of Owner
XCNQ:MYCO Mydecine Innovations Group Inc 2021-02-18 Director

Michael Connolly Latest Holdings Summary

Michael Connolly currently owns a total of 1 stock. Michael Connolly owns 0 shares of Mydecine Innovations Group Inc (XCNQ:MYCO) as of February 18, 2021, with a value of $0.

Latest Holdings of Michael Connolly

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XCNQ:MYCO Mydecine Innovations Group Inc 2021-02-18 0 0.01 0

Holding Weightings of Michael Connolly


Michael Connolly Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael Connolly has made a total of 3 transactions in Mydecine Innovations Group Inc (XCNQ:MYCO) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Mydecine Innovations Group Inc is the sale of 300,000 shares on February 18, 2021, which brought Michael Connolly around $8 Million.

Insider Trading History of Michael Connolly

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael Connolly Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael Connolly Ownership Network

Ownership Network List of Michael Connolly

No Data

Ownership Network Relation of Michael Connolly

Insider Network Chart

Michael Connolly Owned Company Details

What does Mydecine Innovations Group Inc do?

Who are the key executives at Mydecine Innovations Group Inc?

Michael Connolly is the Director of Mydecine Innovations Group Inc. Other key executives at Mydecine Innovations Group Inc include and Senior Officer Damon Michaels .

Mydecine Innovations Group Inc (XCNQ:MYCO) Insider Trades Summary

Over the past 18 months, Michael Connolly made no insider transaction in Mydecine Innovations Group Inc (XCNQ:MYCO). Other recent insider transactions involving Mydecine Innovations Group Inc (XCNQ:MYCO) include a net sale of 50,000 shares made by Damon Michaels , and a net purchase of 600,000 shares made by David Joshua Bartch .

In summary, during the past 3 months, insiders sold 0 shares of Mydecine Innovations Group Inc (XCNQ:MYCO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 50,000 shares of Mydecine Innovations Group Inc (XCNQ:MYCO) were sold and 600,000 shares were bought by its insiders, resulting in a net purchase of 550,000 shares.

Mydecine Innovations Group Inc (XCNQ:MYCO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Mydecine Innovations Group Inc Insider Transactions

No Available Data

Michael Connolly Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Connolly. Currently GuruFocus does not have mailing address information for Michael Connolly.

Discussions on Michael Connolly

No discussions yet.